Cost savings and luteinizing hormone-releasing hormone agonist.
作者信息
Tucker Steven
出版信息
J Oncol Pract. 2006 May;2(3):103. doi: 10.1200/JOP.2006.2.3.103.
Abstract
摘要
相似文献
1
Cost savings and luteinizing hormone-releasing hormone agonist.
J Oncol Pract. 2006 May;2(3):103. doi: 10.1200/JOP.2006.2.3.103.
2
Decreasing use of luteinizing hormone-releasing hormone agonists in the United States is Independent of Reimbursement Changes: A Medicare and Veterans Health Administration claims analysis.
J Urol. 2009 Jul;182(1):255-60; discussion 261. doi: 10.1016/j.juro.2009.02.141. Epub 2009 May 17.
3
A comparison of a powerful luteinizing hormone releasing hormone analogue agonist and estrogen in the treatment of advanced prostatic cancer.
J Urol. 1984 Jun;131(6):1107-9. doi: 10.1016/s0022-5347(17)50832-0.
4
Treatment costs for advanced prostate cancer using luteinizing hormone-releasing hormone agonists: a solid biodegradable leuprorelin implant versus other formulations.
J Comp Eff Res. 2015 Sep;4(5):447-53. doi: 10.2217/cer.14.82. Epub 2014 Dec 18.
5
Mechanisms involved in the pituitary desensitization induced by gonadotropin-releasing hormone agonists.
Am J Obstet Gynecol. 1992 Jul;167(1):283-91. doi: 10.1016/s0002-9378(11)91676-7.
6
Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
Am J Obstet Gynecol. 1979 Nov 15;135(6):759-63. doi: 10.1016/0002-9378(79)90388-0.
7
Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: new insights attained by mass spectrometry.
J Urol. 2012 May;187(5):1601-6. doi: 10.1016/j.juro.2011.12.063. Epub 2012 Mar 14.
8
Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
Am J Obstet Gynecol. 1995 May;172(5):1518-25. doi: 10.1016/0002-9378(95)90490-5.
9
Synthetic polypeptide antagonists of the hypothalamic luteinizing hormone releasing factor.
Science. 1972 May 26;176(4037):933-4. doi: 10.1126/science.176.4037.933.
10
Inhibitory effects of a luteinizing-hormone-releasing hormone agonist implant on ovine fetal gonadotrophin secretion and pituitary sensitivity to luteinizing-hormone-releasing hormone.
J Reprod Fertil. 1992 Nov;96(2):785-92. doi: 10.1530/jrf.0.0960785.
本文引用的文献
1
Individualized strategy for dosing luteinizing hormone-releasing hormone agonists for androgen-independent prostate cancer: identification of outcomes and costs.
J Oncol Pract. 2006 Mar;2(2):57-66. doi: 10.1200/JOP.2006.2.2.57.
2
Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry.
J Clin Endocrinol Metab. 2004 Feb;89(2):534-43. doi: 10.1210/jc.2003-031287.
3
Molecular determinants of resistance to antiandrogen therapy.
Nat Med. 2004 Jan;10(1):33-9. doi: 10.1038/nm972. Epub 2003 Dec 21.
Zotero 插件